Our Spinoffs(34)

  • With our cutting-edge technology, we can produce more with less land, water, and chemicals, thanks to a discovery of the gene that controls how much daily starch is stored in leaves. We also found...

    Read more
  • Carbonade is the developer of a low-temperature CO2 electrolyzer based on abundant, low-cost metals. The company's carbon-to-value project starts with the production of carbon monoxide, one of the...

    Read more
  • On a mission to reduce the global carbon footprint! Ammonia is the second-largest global chemical product. It is being used mainly for agricultural fertilizers (80%), but also as industrial...

    Read more
  • Quantum Art Ltd develops quantum computing system solutions, based on trapped ions. It is a spin-off from the Ozeri group at the Weizmann Institute of Science - the only group with a fully working...

    Read more
  • Sequentify aims to make targeted DNA sequencing as common, fast and affordable as a blood test, enabling significant growth in personalized medicine. 

  • Quantum Source develops the core processing elements for photonic quantum computers. The company is in stealth mode and more information will be revealed in the future.

  • The PointAR System allows PEOPLE in the field to receive critical guidance from expert support staff with existing technologies such as AR, smartphones, tablets, etc.

  • Plethora is a groundbreaking computer game, built in collaboration between researchers at the Weizmann Institute, Forex and MindCET. It’s a simple and pleasant entry point into the world of...

    Read more
  • After decades of research by the global academic community, Quintrigen is on the road to reignite mutant p53 protein, putting it back to work. We are guided by an exceptional team of world-...

    Read more
  • Developing advanced proprietary technologies related to the production of cannabinoid-based active pharmaceutical ingredients ("API") for the pharmaceutical and food industries using biosynthesis...

    Read more
  • Liposphere is a biomedical start-up developing a platform of highly lubricous, water-based biocompatible nanomaterials for conditions in the human body where ultra-low friction is important.

    ... Read more
  • UltraSight, a joint venture of Yeda and NYU, has developed AI-based software that revolutionizes point of care diagnosis using ultrasound imaging, by eliminating the...

    Read more
  • EcoPhage is focused on discovering and developing environmentally friendly products for disease control in agriculture. The company's technology uses bacteriophages (viruses that attack bacteria)...

    Read more
  • Phytolon provides an ultimate solution to the global food colors issue. Leveraging a novel and sustainable technology that is licensed from the Weizmann Institute of...

    Read more
  • FreezeM offers a technology designed to improve the use of insects as a protein source for animal feed. Its products are designed to overcome a number of the limitations of using insects as a...

    Read more
  • Curesponse is a clinical-stage cancer diagnostics company developing a three-dimensional tissue culture system for modeling cancer growth and drug response. The platform preserves the cancer...

    Read more
  • FortePhest is a biotechnology start-up developing a technology to combat herbicide‐resistant weeds.

    FortePhest is developing H-Forte, a herbicide leveraging a recently discovered mechanism...

    Read more
  • EcoBreed develops solutions to fast-track natural plant breeding. The company's technological platform, BreedFit, enables rapid and personalized breeding of plant varieties by learning the farmer'...

    Read more
  • Metabolic Insights aims to develop novel eco-friendly and sustainable products based on purified molecules from plants. The company is developing a new technology platform for the screening,...

    Read more
  • ImmunoBrain Checkpoint (IBC) is a biopharmaceutical company focused on developing a pipeline of disease-modifying immunotherapies for neurological disorders by targeting immune checkpoint pathways...

    Read more
  • DayTwo is a microbiome-based precision medicine company developing personalized nutrition, diagnostic, and therapeutic solutions using artificial intelligence and machine learning. The company's...

    Read more
  • BiomX is a microbiome company developing customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and...

    Read more
  • NanoCell Ltd. is dedicated to advancing women’s reproductive health through biopharmaceutical technologies that significantly improve embryo implantation, consequently increasing the chances of...

    Read more
  • Alma Bio Therapeutics is a biotechnology company pioneering a new class of therapeutic that reinforces the natural built-in mechanism for disease resolution and healing and restores the ability of...

    Read more
  • miCure Therapeutics is a biotechnology company leveraging microRNA-based therapeutics and diagnostics for neurodegenerative and psychiatric disorders. Its microRNA therapeutics and diagnostics for...

    Read more
  • SynVaccine has developed a CAD/CAM platform for designing and fabricating designer viruses for biotechnology. The company utilizes a multidisciplinary approach combining technologies, such as...

    Read more
  • Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company's patented Veto Cell technology enables safe and...

    Read more
  • LifeMap Sciences develops and commercializes next-generation sequencing (NGS) analysis solutions. The company's core technology, the GeneCards Suite Knowledgebase, provides a tool to improve...

    Read more
  • Kadimastem develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as amyotrophic lateral sclerosis (ALS)...

    Read more
  • Immunity Pharma (IPL) develops therapies for neurodegenerative diseases with an initial focus on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

    IPL's drugs are...

    Read more
  • IDEA Bio-Medical is a commercial-stage company specializing in solutions for biological cell-imaging research, drug-discovery automation, and diagnostics. The company's product platforms are built...

    Read more
  • BiondVax Pharmaceuticals is a biotechnology company focused on developing, manufacturing, and...

    Read more
  • NanoMaterials produces commercially viable inorganic, multilayered nanofullerenes and nanotubes based on patented platform technology developed at the Weizmann Institute of Science. The company's...

    Read more
  • Neurogenic is a clinical-stage diagnostics company advancing the development of a novel ELISA-based immunoassay to detect pathological Platelet-Associated Antibodies (PAA) in the sera of...

    Read more